Terms: = Leukemia AND FCRL4, FCRH4, 83417, ENSG00000163518, IRTA1, IGFP2
5 results:
1. Relevance of Additional Immunohistochemical Markers in the Differential Diagnosis of Small B-Cell Lymphomas: A Case-Control Study.
Kıvrak H; Yüksel S; Ateş C; Merter M; Kaygusuz G; Özcan M; Kuzu I
Turk J Haematol; 2022 Aug; 39(3):178-187. PubMed ID: 34619856
[TBL] [Abstract] [Full Text] [Related]
2. Immunohistochemical analysis of the novel marginal zone B-cell marker irta1 in malignant lymphoma.
Ikeda JI; Kohara M; Tsuruta Y; Nojima S; Tahara S; Ohshima K; Kurashige M; Wada N; Morii E
Hum Pathol; 2017 Jan; 59():70-79. PubMed ID: 27666766
[TBL] [Abstract] [Full Text] [Related]
3. Fc receptor-like 1-5 molecules are similarly expressed in progressive and indolent clinical subtypes of B-cell chronic lymphocytic leukemia.
Kazemi T; Asgarian-Omran H; Hojjat-Farsangi M; Shabani M; Memarian A; Sharifian RA; Razavi SM; Jeddi-Tehrani M; Rabbani H; Shokri F
Int J Cancer; 2008 Nov; 123(9):2113-9. PubMed ID: 18704934
[TBL] [Abstract] [Full Text] [Related]
4. Expression pattern of the human FcRH/IRTA receptors in normal tissue and in B-chronic lymphocytic leukemia.
Polson AG; Zheng B; Elkins K; Chang W; Du C; Dowd P; Yen L; Tan C; Hongo JA; Koeppen H; Ebens A
Int Immunol; 2006 Sep; 18(9):1363-73. PubMed ID: 16849395
[TBL] [Abstract] [Full Text] [Related]
5. Rapid amplification of immunoglobulin heavy chain switch (IGHS) translocation breakpoints using long-distance inverse PCR.
Sonoki T; Willis TG; Oscier DG; Karran EL; Siebert R; Dyer MJ
Leukemia; 2004 Dec; 18(12):2026-31. PubMed ID: 15496980
[TBL] [Abstract] [Full Text] [Related]
